Y Intercept (Hong Kong) LTD Seres Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.93 - $2.15 $66,516 - $153,774	71,523 New	71,523 $100,000
Q2 2022 Aug 08, 2022	BUY	$2.7 - $7.62 $38,680 - $109,164	14,326 New	14,326 $49,000
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $62,702 - $259,538	-11,484 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$18.46 - $24.36 $211,994 - $279,750	11,484 New	11,484 $274,000
Q2 2021 Aug 12, 2021	BUY	$18.46 - $24.36 $0 - $0	0 New	0 $274,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.